Profil
Rémi Delansorne served as the Chief Executive Officer & Director at Hybrigenics SA from 2007 to 2017.
Prior to that, he worked at Hybrigenics SA from 2004 to 2020.
He also worked as the Head-Diabetes Research at Merck Serono Ltd. Dr. Delansorne holds a doctorate degree from Université Pierre et Marie Curie and a doctorate degree from École Nationale Vétérinaire d'Alfort.
Tidigare kända positioner av Rémi Delansorne
| Företag | Position | Slut |
|---|---|---|
| ATON | Verkställande Direktör | 2020-03-12 |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Företagsledare/Principal | - |
Rémi Delansornes utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 4 |
|---|---|
Hybrigenics SA
Hybrigenics SA Pharmaceuticals: MajorHealth Technology Develops therapeutic molecules and genomics | Health Technology |
Université Pierre et Marie Curie
Université Pierre et Marie Curie Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Serono Ltd.
Merck Serono Ltd. Miscellaneous Commercial ServicesCommercial Services Provides research and development services and manufactures medicinal drugs | Commercial Services |
École Nationale Vétérinaire d'Alfort
École Nationale Vétérinaire d'Alfort Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















